Patent details
LUC50001 Product Name: Autologous anti-CD19-transduced CD3+ cells (brexucabtagene autoleucel)
Basic Information
- Publication number:
- LUC50001
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP157463993
- Legal Status:
- Pending & Published
- Application number:
- LUC50001
- First applicant's nationality:
- Procedural language:
- English
Marketing Authorization
- Marketing Authorization Number:
- EU/1/20/1492
- Marketing Authorization Type:
- Marketing Authorization Date:
- 15/12/2020
- Marketing Authorization Status:
- Claimed
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 20/02/2025
- First Marketing Authorization date:
- 15/12/2020
- Grant date:
- Activation date:
- Publication date:
- 24/02/2025
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 15/12/2035
- SPC Extension Expiration:
- 15/12/2035
- Rejection date:
- Withdrawal date:
Owner
- From:
- 20/02/2025
- Name:
- Kite Pharma, Inc.
- Address:
- 2400 Broadway, Santa Monica, CA 90404, United States (US)
- Name:
- The United States of America, as Represented by The Secretary, Department of Health and Human Services
- Address:
- Office of Technology Transfer National Institutes of Health 6701 Rockledge Drive Suite 700, MSC 7788, Bethesda, Maryland 20892-7788, United States (US)
Agent
- Name:
- MARKS & CLERK LLP
- From:
- 20/02/2025
- Address:
- BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
- To:
Publication
Bulletin
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2025/04
- Publication date:
- 04/03/2025
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
| Filing date | Document type | Number of pages |
|---|---|---|
| 20/02/2025 | Application Form | 6 |
| 20/02/2025 | General Document | 44 |
| 20/02/2025 | Outgoing Correspondence | 3 |
| 20/02/2025 | General Document | 7 |
| 20/02/2025 | General Document | 5 |
| 20/02/2025 | General Document | 5 |
| 20/02/2025 | General Document | 5 |
| 20/02/2025 | General Document | 7 |
| 20/02/2025 | General Document | 14 |
| 20/02/2025 | General Document | 3 |
| 20/02/2025 | General Document | 48 |
| 20/02/2025 | General Document | 5 |
| 20/02/2025 | General Document | 1 |
| 20/02/2025 | General Document | 38 |
| 20/02/2025 | General Document | 26 |
| 20/02/2025 | General Document | 131 |
| 20/02/2025 | General Document | 1 |
| 24/02/2025 | Outgoing Correspondence | 1 |
| 24/02/2025 | Publication | 1 |